NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 256 filers reported holding NEOGENOMICS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,150,728 | -26.6% | 987,864 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $16,564,122 | -10.3% | 1,030,748 | -2.9% | 0.00% | -25.0% |
| Q1 2023 | $18,476,188 | +85.5% | 1,061,240 | -1.5% | 0.00% | +100.0% |
| Q4 2022 | $9,958,705 | +4.8% | 1,077,782 | -2.3% | 0.00% | 0.0% |
| Q3 2022 | $9,501,000 | +10.7% | 1,103,581 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $8,584,000 | -40.4% | 1,053,171 | -11.1% | 0.00% | -33.3% |
| Q1 2022 | $14,400,000 | -69.6% | 1,185,209 | -14.7% | 0.00% | -66.7% |
| Q4 2021 | $47,409,000 | -30.7% | 1,389,489 | -2.0% | 0.01% | -30.8% |
| Q3 2021 | $68,417,000 | +8.9% | 1,418,236 | +2.0% | 0.01% | +8.3% |
| Q2 2021 | $62,816,000 | -7.5% | 1,390,657 | -1.2% | 0.01% | -14.3% |
| Q1 2021 | $67,917,000 | -10.5% | 1,408,172 | -0.1% | 0.01% | -17.6% |
| Q4 2020 | $75,917,000 | +46.2% | 1,410,039 | +0.2% | 0.02% | +30.8% |
| Q3 2020 | $51,935,000 | +18.1% | 1,407,856 | -0.9% | 0.01% | +8.3% |
| Q2 2020 | $43,991,000 | +9.1% | 1,419,982 | -2.8% | 0.01% | -7.7% |
| Q1 2020 | $40,325,000 | -9.9% | 1,460,560 | -4.6% | 0.01% | +8.3% |
| Q4 2019 | $44,778,000 | +57.2% | 1,530,925 | +2.8% | 0.01% | +50.0% |
| Q3 2019 | $28,483,000 | -15.6% | 1,489,724 | -3.1% | 0.01% | -11.1% |
| Q2 2019 | $33,733,000 | -9.9% | 1,537,485 | -16.0% | 0.01% | -10.0% |
| Q1 2019 | $37,446,000 | +279.4% | 1,830,240 | +133.8% | 0.01% | +233.3% |
| Q4 2018 | $9,870,000 | -27.1% | 782,790 | -11.3% | 0.00% | 0.0% |
| Q3 2018 | $13,543,000 | +47.6% | 882,244 | +26.0% | 0.00% | +50.0% |
| Q2 2018 | $9,177,000 | +59.9% | 700,072 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $5,740,000 | -20.8% | 703,512 | -14.0% | 0.00% | 0.0% |
| Q4 2017 | $7,249,000 | -33.7% | 818,196 | -16.7% | 0.00% | -33.3% |
| Q3 2017 | $10,935,000 | +29.3% | 982,560 | +4.1% | 0.00% | +50.0% |
| Q2 2017 | $8,456,000 | +36.9% | 943,784 | +20.5% | 0.00% | 0.0% |
| Q1 2017 | $6,178,000 | -16.3% | 783,011 | -9.1% | 0.00% | 0.0% |
| Q4 2016 | $7,385,000 | +0.1% | 861,720 | -4.0% | 0.00% | 0.0% |
| Q3 2016 | $7,380,000 | +13.3% | 897,824 | +10.8% | 0.00% | 0.0% |
| Q2 2016 | $6,514,000 | +158.1% | 810,167 | +116.4% | 0.00% | +100.0% |
| Q1 2016 | $2,524,000 | -0.9% | 374,361 | +15.7% | 0.00% | 0.0% |
| Q4 2015 | $2,547,000 | +175.4% | 323,630 | +100.6% | 0.00% | – |
| Q3 2015 | $925,000 | -29.5% | 161,300 | -33.5% | 0.00% | – |
| Q2 2015 | $1,312,000 | +216.1% | 242,605 | +173.1% | 0.00% | – |
| Q1 2015 | $415,000 | +3.8% | 88,844 | -7.4% | 0.00% | – |
| Q4 2014 | $400,000 | -30.4% | 95,916 | -13.1% | 0.00% | – |
| Q3 2014 | $575,000 | +159.0% | 110,327 | +64.3% | 0.00% | – |
| Q2 2014 | $222,000 | -50.3% | 67,148 | -47.9% | 0.00% | – |
| Q1 2014 | $447,000 | -5.3% | 128,846 | -1.1% | 0.00% | – |
| Q4 2013 | $472,000 | -20.5% | 130,293 | -34.1% | 0.00% | – |
| Q3 2013 | $594,000 | +50.8% | 197,730 | +99.3% | 0.00% | – |
| Q2 2013 | $394,000 | – | 99,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |